Tag: Axitinib

TACITO: Does faecal microbiota transplantation improve survival in mRCC?

Presented By
Dr Gianluca Ianiro, Agostino Gemelli University Policlinic, Italy
Trial
Phase 2, TACITO
Conference
UEGW 2024
Type
Peer-reviewed article

28 November 2024 11:19

Biomarkers for treatment of renal cell carcinoma

Trial
Phase 3, CLEAR, KEYNOTE-426, IMmotion010
Conference
ASCO 2024
Type
Peer-reviewed article

18 July 2024 14:00

High-risk early RCC may benefit from neoadjuvant avelumab plus axitinib

Presented By
Dr Axel Bex, Netherlands Cancer Institute, the Netherlands
Trial
Phase 2, NeoAvAx
Conference
ASCO GU 2022
Type
Peer-reviewed article

8 April 2022 11:14

Combined nivolumab/axitinib treatment elicits good response in metastatic RCC

Presented By
Dr Matthew Zibelman, Fox Chase Cancer Center, PA, USA
Trial
Phase 1/2
Conference
ASCO GU 2022
Type
Peer-reviewed article

8 April 2022 11:13

Axitinib offers hope for improving renal cell cancer surgical outcomes

Presented By
Prof. Grant Stewart, University of Cambridge, UK
Trial
Phase 2, NAXIVA
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:53

No benefit of adding axitinib to ocreotide acetate in non-pancreatic neuroendocrine tumours

Presented By
Dr Rocio Garcia-Carbonero, Hospital Universitario 12 de Octubre, Spain
Trial
Phase 3, AXINET trial-GETNE-1107
Conference
ASCO GI 2021
Type
Peer-reviewed article

12 March 2021 10:44

Toripalimab plus axitinib effective in metastatic mucosal melanoma

Presented By
Dr Xinan Sheng, Peking University Cancer Hospital and Institute, China
Trial
Phase 1
Conference
ASCO 2020
Type
Peer-reviewed article

28 August 2020 14:13

KEYNOTE-426: no QoL differences pembrolizumab + axitinib versus sunitinib

Presented By
Prof. Jens Bedke, University of Tübingen, Germany
Trial
Phase 3, KEYNOTE-426
Conference
EAU 2020
Type
Peer-reviewed article

20 August 2020 10:41
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com